Related Blog Posts
Medicago reports positive Phase I results for its avian flu pandemic vaccine
21 hours ago ago from Life Sciences Blog
Story Summary: (TSX-V: MDG) a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today reported positive interim results from a Phase I human clinical trial with its H5N1 Avian Influenza vaccine candidate (H5N1 vaccine). The vaccine was found to be safe, well tolerated and also induced a solid immune response. It may also allow ...
Related contentRelated News
Nothing to see... move along.
Related Videos
Nothing to see... move along.
